RxFiber llc Announces Issuance of U.S. Patent No. 10,835,645 Covering High-Tenacity Fibers for Use in Sterilized Medical Devices.

Share Article

RxFiber LLC, a privately held, biotextile company focused on innovative and differentiated fibers for the medical device industry, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,835,645, on November 17, 2020, which is directed to methods related to the production of high tenacity fibers for use in sterilized medical devices.

Patented RxFibron HT medical grade fiber from RxFiber

Patented RxFibron HT

“We are pleased to have been awarded this important patent that we believe will provide medical device manufacturers an innovative alternative to UHMWPE and standard polyester,” says Brenda Gilchrist President of RxFiber llc.

RxFiber LLC, a privately held, biotextile company focused on innovative and differentiated fibers for the medical device industry, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,835,645, on November 17, 2020, which is directed to methods related to the production of high tenacity fibers for use in sterilized medical devices.

RxFiber llc’s patented high tenacity fiber is marketed as RxFibron HT©, a high tenacity fiber developed to revolutionize sterilized medical devices.

RxFiber llc is actively seeking potential partners to license or purchase the patented technology for the development of lower-profile sterilized devices or other suitable applications.

“We are pleased to have been awarded this important patent that we believe will provide medical device manufacturers an innovative alternative to UHMWPE and standard polyester,” says Brenda Gilchrist President of RxFiber llc.

Inventor Robert Torgerson says, “RxFibron HT© has several advantages over existing polyesters, including lower denier, durability, high strength, and custom size variations suitable for creating lower-profile devices.”

The revolutionary patented RxFibron HT© is the first commercially available high tenacity, medical grade polyester biomaterial that can be used to create next-generation implantable devices, such as sutures, composites, and more for applications such as endovascular, vascular, and orthopedics.

Ms. Gilchrist, President of RxFiber llc says, “RxFibers’ patented high tenacity polyester fiber was invented because physicians were looking for smaller delivery systems to deliver devices in a transcatheter application and mitigate trauma to the patient.”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Gilchrist
RXFIBER, LLC
+1 866-308-6025 Ext: 11
Email >

Brenda Gilchrist
RxFiber, LLC
1-866-308-6025 11
Email >
Visit website